Literature DB >> 20675750

Uncemented custom computer-assisted design and manufacture of hydroxyapatite-coated femoral components: survival at 10 to 17 years.

S K Muirhead-Allwood1, N Sandiford, J A Skinner, J Hua, C Kabir, P S Walker.   

Abstract

We present the 10- to 17-year results of 112 computer-assisted design computer-assisted manufacture femoral components. The total hip replacements were performed between 1992 and 1998 in 111 patients, comprising 53 men and 58 women. Their mean age was 46.2 years (24.6 to 62.2) with a mean follow-up of 13 years (10 to 17). The mean Harris Hip Score improved from 42.4 (7 to 99) to 90.3 (38 to 100), the mean Oxford Hip Score from 43.1 (12 to 59) to 18.2 (12 to 51) and the mean Western Ontario MacMasters University Osteoarthritis Index score from 57.0 (7 to 96) to 11.9 (0 to 85). There was one revision due to failure of the acetabular component but no failures of the femoral component. There were no revisions for aseptic loosening. The worst-case survival in this cohort of custom femoral components at 13.2 years follow-up was 98.2% (95% confidence interval 95 to 99). Overall survival of this series of total hip replacements was 97.3% (95% confidence interval 95 to 99). These results are comparable with the best medium- to long-term results for femoral components used in primary total hip replacement with any means of fixation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675750     DOI: 10.1302/0301-620X.92B8.23123

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  10 in total

Review 1.  [Total hip arthroplasty in young patients : Bearings and custom-made prostheses].

Authors:  C Benignus; M Morlock; J Beckmann
Journal:  Orthopade       Date:  2019-04       Impact factor: 1.087

2.  Stable fixation of short-stem femoral implants in patients 70 years and older.

Authors:  Ronak M Patel; Matthew C Smith; Chase C Woodward; S David Stulberg
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

3.  In vivo testing of canine prosthetic femoral components with HA-Ti ladder-type coating on vacuum plasma-sprayed Ti substrate.

Authors:  Xian-Lin Zeng; Jing-Feng Li; Shu-Hua Yang; Qi-Xin Zheng; Zhen-Wei Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

4.  Patient-specific devices and population-level evidence: evaluating therapeutic interventions with inherent variation.

Authors:  Mary Jean Walker
Journal:  Med Health Care Philos       Date:  2018-09

5.  Calcium orthophosphate coatings, films and layers.

Authors:  Sergey V Dorozhkin
Journal:  Prog Biomater       Date:  2012-09-26

6.  Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women: a 2-year RSA study of 39 patients.

Authors:  Hannu T Aro; Jessica J Alm; Niko Moritz; Tatu J Mäkinen; Petteri Lankinen
Journal:  Acta Orthop       Date:  2012-04-11       Impact factor: 3.717

Review 7.  Bone Regeneration Based on Tissue Engineering Conceptions - A 21st Century Perspective.

Authors:  Jan Henkel; Maria A Woodruff; Devakara R Epari; Roland Steck; Vaida Glatt; Ian C Dickinson; Peter F M Choong; Michael A Schuetz; Dietmar W Hutmacher
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

8.  Custom hemiarthroplasties for retention of existing hardware associated with osteogenesis imperfecta.

Authors:  Kevin Nishida; Daniel Choi; Mathias Bostrom
Journal:  Arthroplast Today       Date:  2017-03-03

9.  Long-term results of the custom- made hip endoprostheses Evolution K® and Adaptiva®: A prospective cohort study.

Authors:  Steffen Axt; Andreas Kirschniak; Lena Axt; Manuel Braun; Christian Beltzer; Carmen Leichtle; Ulf Leichtle
Journal:  Orthop Rev (Pavia)       Date:  2021-04-07

10.  Medium-term follow-up of 92 femoral component revisions using a third-generation cementing technique.

Authors:  Martijn A J Te Stroet; Wim H C Rijnen; Jean W M Gardeniers; Albert Van Kampen; B Willem Schreurs
Journal:  Acta Orthop       Date:  2015-11-16       Impact factor: 3.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.